Full text is available at the source.
Abstract
The role of glucagon-like peptide-1 receptor (GLP-1R) activation in Alzheimer's disease risk is still uncertain.
- GLP-1R activation may influence Alzheimer's disease risk through various mechanisms.
- The potential effects could involve improvements in metabolism or direct protective effects on nerve cells.
- Current understanding does not clarify whether these effects are primarily indirect or direct.
Simplified
GLP-1 Therapies